Insights on the Global Depression Therapeutics Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global depression therapeutics market is expected to grow at a significant CAGR during the forecast period (2021-2027). The rise in the geriatric population and changes in people's lifestyles are two primary factors driving the market growth. The ageing population is anticipated to grow continuously, at a uniform rate in the next 10 years. For instance, according to the World Health Organization (WHO), the number of people aged 60 years or above was around 900 million in 2015 and it is estimated to reach nearly 2.0 billion in 2050, with most of the increase in the developing countries. In 2019, in Japan, people aged 65 years or above held 28% of the total country’s population (126 million) and followed by it, Italy held 23%. Depression is one of the major conditions amongst older people having a significant effect on their well-being and quality of life.
To Request a Sample of our Report on Global Depression
Therapeutics Market: https://www.omrglobal.com/request-sample/depression-therapeutics-market
People are being made aware of depression through public awareness
campaigns. Although public awareness is growing, this ailment is still
underdiagnosed and undertreated. The patient is treated with a combination of
psychotherapy and antidepressants. Selective serotonin reuptake inhibitors are
predicted to lead the drug class segment during the forecast period owing to
the high level of effectiveness and general safety. Additionally, North America
depression therapeutics market is significantly driven by significant
antidepressant consumption in the US, branded medications, and an active
lifestyle. Moreover, Europe depression therapeutics market is driven by the
rising public knowledge about depression and improved healthcare facilities and
initiatives by various government and non-government organisations.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Pfizer,
Inc., Eli Lilly Co., H. Lundbeck A/S, and Otsuka Holdings Co., Ltd., among
others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Depression Therapeutics Market is Available
at: https://www.omrglobal.com/industry-reports/depression-therapeutics-market
Global Depression Therapeutics Market Report by Segment
By Drug Type
• Antidepressants
• Antipsychotics
• Others
By Indication
• Major Depressive
Disorder (MDD)
• Bipolar Disorder
• Seasonal Affective
Disorder (SAD)
• Premenstrual Dysphoric
Disorder (PMDD)
• Others
By Distribution Channel
• Hospital
Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Depression Therapeutics Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment